Detalles de la búsqueda
1.
Ovarian tumor frozen section, a multidisciplinary affair.
Acta Oncol;
61(7): 785-792, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35611589
2.
The role of computed tomography in the assessment of tumour extent and the risk of residual disease after upfront surgery in advanced ovarian cancer (AOC).
Arch Gynecol Obstet;
306(4): 1235-1243, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35235024
3.
Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960-2014: A population-based cohort study.
BMC Cancer;
21(1): 465, 2021 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33902507
4.
A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer.
Mol Cell Proteomics;
18(9): 1836-1850, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31289117
5.
High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer.
Gynecol Oncol;
159(3): 860-868, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33032823
6.
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.
Lancet Oncol;
20(10): 1409-1419, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31474354
7.
Pattern of endocrine treatment for epithelial ovarian cancer in the Southeast medical region of Sweden: a population-based study.
Acta Oncol;
58(3): 320-325, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30632888
8.
Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial.
Lancet Oncol;
19(8): 1117-1125, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30026000
9.
Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response.
Int J Gynecol Pathol;
37(2): 101-109, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28481779
10.
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet Oncol;
17(1): 78-89, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26590673
11.
Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO).
BMC Cancer;
14: 68, 2014 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24498853
12.
Age and Referral Route Impact the Access to Diagnosis for Women with Advanced Ovarian Cancer.
J Multidiscip Healthc;
16: 1239-1248, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37163196
13.
Tru-Cut Biopsy in Gynecological Cancer: Adequacy, Accuracy, Safety and Clinical Applicability.
J Multidiscip Healthc;
16: 1367-1377, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37215751
14.
Prognostic Value of Peritoneal Cancer Index After Complete Cytoreductive Surgery in Advanced Ovarian Cancer.
Anticancer Res;
42(5): 2541-2551, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35489749
15.
Ovarian cancer linked to Lynch syndrome typically presents as early-onset, non-serous epithelial tumors.
Gynecol Oncol;
121(3): 462-5, 2011 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21388660
16.
MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer.
Genes (Basel);
12(5)2021 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34069138
17.
A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
PLoS One;
15(10): e0240418, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33075095
18.
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma.
Virchows Arch;
477(1): 83-91, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31980961
19.
SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery.
Mol Cell Oncol;
7(6): 1805094, 2020 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33235906
20.
Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method.
Sci Rep;
9(1): 15506, 2019 10 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31664085